secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cano Health, Inc. (—)
CIK:        0001800682
Form:       8-K
Filed at:   2023-06-20T23:59:59+00:00
Accession:  0001193125-23-169651
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cano Health CEO Marlow Hernandez resigns; Mark Kent appointed Interim CEO
-------------------------------------------------------------------------

- CEO Marlow Hernandez resigned effective June 16, 2023; remains on Board.
- Mark Kent, current Chief Strategy Officer, appointed Interim CEO effective immediately.
- Kent receives $475k base salary, $325k target cash incentive, $1.5M annual equity, $1.5M RSUs vesting June 2024.
- Board will conduct external search for permanent CEO and refresh Board with new independent directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1800682/000119312523169651/0001193125-23-169651-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1800682/000119312523169651/d512837d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-169651

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer